| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/15/2004 | EP1456357A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 09/15/2004 | EP1456356A2 Method of producing human beta cell lines |
| 09/15/2004 | EP1456355A2 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 09/15/2004 | EP1456354A2 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof |
| 09/15/2004 | EP1456351A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 09/15/2004 | EP1456230A2 Flavivirus ns1 subunit vaccine |
| 09/15/2004 | EP1455840A2 Treatment of human cancer with adenoviral vector expressing tnf-alpha |
| 09/15/2004 | EP1455836A2 Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 09/15/2004 | EP1455829A1 Treating vascular disease by inhibiting myeloid differentiation factor 88 |
| 09/15/2004 | EP1455818A2 Applications of spores |
| 09/15/2004 | EP1455797A2 Pseudopterosin compounds of symbiodinium spp isolated from pseudopterogorgia elisabethae |
| 09/15/2004 | EP1455754A2 Pharmaceutical compositions in particulate form |
| 09/15/2004 | EP1414944A4 Methods for ex vivo propagation of somatic stem cells |
| 09/15/2004 | EP1001806B1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0733104B1 Purification of vitamin-k dependent proteins by membrane chromatography |
| 09/15/2004 | EP0707644B1 Use of pharmaceutical compositions for the treatment of neurodegenerative diseases |
| 09/15/2004 | EP0671910B1 Use of adamantane derivatives for the manufacture of a medicament in the TREATMENT of glaucoma |
| 09/15/2004 | EP0647275B1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 09/15/2004 | CN2640514Y Health care cover |
| 09/15/2004 | CN1529758A Novel expression vectors and uses thereof |
| 09/15/2004 | CN1529753A Disease-associated protein |
| 09/15/2004 | CN1529618A Induction of tolerance |
| 09/15/2004 | CN1529608A Remedies for dermatophytosis |
| 09/15/2004 | CN1529607A Treatment of T cell disorders |
| 09/15/2004 | CN1529604A Drug for treatment of osteonecrosis and for management of patients at risk of evelopment osteonecrosis |
| 09/15/2004 | CN1528477A Inject-discharge physiotherapy device |
| 09/15/2004 | CN1528434A Chinese medicine composition for treating myopia and preparing method thereof |
| 09/15/2004 | CN1528418A Chinese medicine for treating pelvis, nephritis and kidney injury and preparing method thereof |
| 09/15/2004 | CN1528375A Chinese medicine for treating protrasion of the lumber intervertebral disci |
| 09/15/2004 | CN1528368A Powder for treating eye disease and preparing method thereof |
| 09/15/2004 | CN1528355A Chinese medicine comp osition for treating spondylodynia |
| 09/15/2004 | CN1528349A Health-care medicinal composition, and preparing method and use thereof |
| 09/15/2004 | CN1528348A Method for preparing novel anti-cancer medicine |
| 09/15/2004 | CN1528347A Nano-level pearl powder-conch powder biological calcium tablet |
| 09/15/2004 | CN1528346A Oculentum for treating eye disease and preparing method thereof |
| 09/15/2004 | CN1528345A Preparation method for producing instant-dissolving pearl refined powder by pearl hydrolyzation and denucleation |
| 09/15/2004 | CN1166773C Differentiation of adipose stromal cells into osteobalsts |
| 09/15/2004 | CN1166687C Medicine combined by moleculae of growth factor and traumatic factor in gall |
| 09/15/2004 | CN1166409C Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype |
| 09/15/2004 | CN1166393C Wound spray for treating burn |
| 09/15/2004 | CN1166392C Pain-stopping ointment |
| 09/15/2004 | CN1166384C Medicine for relieving cough and asthma |
| 09/15/2004 | CN1166383C Medicine for treating tumor in digestive tract and its prepn |
| 09/15/2004 | CN1166381C Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation |
| 09/15/2004 | CN1166380C Plaster for treating infantile parotitis and its preparing process |
| 09/15/2004 | CN1166379C Medicine for treating kidney disease and method for preparing same |
| 09/15/2004 | CN1166378C 'Tongyuhuazhi' pill |
| 09/15/2004 | CN1166377C Medicine for treating woman's acyesis |
| 09/15/2004 | CN1166376C Powder medicine for treating hepatitis A and B |
| 09/15/2004 | CN1166375C Heart disease treating medicine |
| 09/15/2004 | CN1166374C Hemiplegia treating pill |
| 09/15/2004 | CN1166372C Formula of medicine for treating myopia and preparation process thereof |
| 09/15/2004 | CN1166371C Use of propionic bacteria for producing propionic acid and/or propionates in colon |
| 09/15/2004 | CN1166370C New medicine for curing cerebral thrombosis |
| 09/15/2004 | CN1166369C Nano level pilose antler and pilose antler product and their prepn process |
| 09/15/2004 | CN1166368C Seal oil cream and its prepn process and application in preparing intravenous injection |
| 09/15/2004 | CN1166367C Medicine for external application for curing psoriasis |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790823 Compositions and methods for the prevention and treatment of cardiovascular diseases |
| 09/14/2004 | US6790455 Biodegradation membrane |
| 09/14/2004 | US6790450 Use of coxiella bacteria to treat autoimmune disease |
| 09/14/2004 | US6790441 Sertoli cells as biochambers |
| 09/14/2004 | US6790434 Sunscreen agents; mixture of deactivated bacteria and plant extract |
| 09/14/2004 | CA2422245A1 Methods for the treatment of cellular proliferative disorders |
| 09/14/2004 | CA2161659C Retinal pigment epithelium transplantation |
| 09/10/2004 | WO2004076652A1 Medium for stem cells to be used in intervertebral disk generation and regeneration of intervertebral disk using stem cells |
| 09/10/2004 | WO2004075988A2 Methods of immunomodulation in animals |
| 09/10/2004 | WO2004075935A1 Method for cleaning a bone-graft material |
| 09/10/2004 | WO2004075878A1 Fatty emulsion injection of seal oil, method for preparation and the use in manufacturing intravenous injection |
| 09/10/2004 | WO2004075660A1 Food and drug containing royal jelly |
| 09/10/2004 | WO2004053096A3 Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 09/10/2004 | WO2004043222A3 Treating carcinoid neoplasms with therapeuthic viruses |
| 09/10/2004 | WO2004016731A3 Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| 09/10/2004 | WO2004009027A3 Method and composition for treating and preventing herpesvirus infection |
| 09/10/2004 | WO2003030822A3 Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same |
| 09/10/2004 | WO2003030816A3 Combinatorial anti-acne compositions |
| 09/10/2004 | CA2517108A1 Medium for stem cells in regeneration of intervertebral disc and regeneration of intervertebral disc using stem cells |
| 09/09/2004 | US20040177395 Immune cloning and uses thereof |
| 09/09/2004 | US20040177394 Using nuclear transfer of preferentially immune responsive genomes to generate vaccinated transgenic mammals; tissue engineering |
| 09/09/2004 | US20040176318 Pretreating with lipophilic substituted saccharide |
| 09/09/2004 | US20040176310 Use of extracts and preparations from iris plants and tectorigenin as medicaments |
| 09/09/2004 | US20040176275 Pharmaceutical composition for alleviating tissue hypoxia and methods for alleviating tissue hypoxia |
| 09/09/2004 | US20040175827 used to treat graft-versus-host-disease, tumors, and autoimmune disorders; solid phase synthesis |
| 09/09/2004 | US20040175826 for isolating chondrocytes from mandibular condyle tissue and being depleted of fibroblast-like cells and/or myocytes; enzyme inhibitors |
| 09/09/2004 | US20040175823 Isolation of spore-like cells from tissues exposed to extreme conditions |
| 09/09/2004 | US20040175436 synthetic zeolites and selected herbal proteins (MPP) which is applied for prevention of the development of neuropathies in persons suffering diabetes; stops the process of apoptosis caused by accumulation of Ca2+ ions in cytplasm of nerve cells |
| 09/09/2004 | US20040175412 Capsules containing vital cells or tissues |
| 09/09/2004 | US20040175389 Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life |
| 09/09/2004 | US20040175375 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 09/09/2004 | US20040175374 Therapeutic platelets and methods |
| 09/09/2004 | US20040175373 Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 09/09/2004 | US20040175372 Inhibits rotavirus infection and other pathogenic microorganisms; viricides; preventing and treating diarrhea of mammals, livestock, and poultry |
| 09/09/2004 | US20040175371 Introducing a biological material into a patient |
| 09/09/2004 | US20040175367 Culture comprising artificial stroma comprising mixture of collagen, human fibroblasts from colon or intestine; overlayed with epithelial cells; and growth factor that binds receptors of insulin growth factor, epidermal growth factor, and/or leukemia inhibitory factor; drug screening, wound healing |
| 09/09/2004 | US20040175366 Comprising devitalized mammalian parenchymatous tissue combined with target mammalian cell population sized and shaped for implantation at anatomical site in patient remote from tissue requiring regeneration; |
| 09/09/2004 | US20040175365 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 09/09/2004 | US20040175364 Gene transfer with adenoviruses having modified fiber proteins |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175362 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |